🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Can we "read" microbial genomes using language models? We explore this idea in our paper "Deciphering microbial gene function using natural language processing" nature.com/articles/s4146… 🧵

Meet The Shielded Plasmid🛡️🧬 Our new nature paper reveals how plasmids outsmart bacterial defenses during conjugation. It's all about being in the right place at the right time! The positioning of anti-defense genes boosts transfer efficiency🧵(1/7) nature.com/articles/s4158…

ממש שמח להצטרף לקוונורג'-ביו בסבב הסיד שלהם. עוד על מה הם עושים בטקרנצ'. יש להם כבר צוות פסיכי, והם מחפשים עוד. חיבור מרתק של ביו ו-AI עם אנשים מופלאים, נחמדים, וחדורי מטרה 🎯. Converge Bio Dov Gertz #פידטק

During my sabbatical, one project I really enjoyed was training DNA foundation models with the team at Arc Institute. I've long believed that deep learning should unlock unprecedented improvements in medicine and healthcare — not just for humans but for animals too. I think this

היי כולם! ביום שלישי הקרוב אארח בספייס את Dov Gertz, המייסד והמנכל של Converge Bio, ונשוחח על המסע שלו בתעשיה ועל פלטפורמת הGenAI שהם בונים שמנגישה LLMs לדאטה-סטים ביולוגיים עבור האצת מחקר ופיתוח של תרופות. בואו :) לספייס: x.com/i/spaces/1BdxY…

למי שפספס את הספייס אמש, שוחחתי עם Dov Gertz על: - השנים באקדמיה והמחקר שלו סביב מנגנוני CRISPR (כולל מה זה בכלל?) - סיפור ההקמה של Converge Bio ואיזו בעיה כואבת הם פותרים בעולמות הגנטיקה בעזרת GenAI? - למה הוא אגנוסטי לורטיקל שהם פועלים בו? (תרופות, אגרוטק, ביוטק וכו׳). -

Instead of looking at the S&P500 go down, you can look at the number of biological models and datasets on Hugging Face go up.

At Converge Bio we are building AI-powered solutions across the entire drug life cycle, from R&D to production, such as binder design, transcript optimization target discovery, and drug MoC with RNA single-cell sequencing

FDA shifts from animal testing for mAbs & drugs! New roadmap embraces AI models & human-based NAMs for safety. Huge step for ethics & faster dev! But what if GenAI could generate antibodies too, not just test them? Combine FDA's move + AI design = skip animal use entirely!

Converge Bio uses #GenerativeAI for de novo & guided antibody generation, optimizing binding, developability & specificity. We're building the future of ethical, efficient antibody discovery. Wondering how to leverage this for your org? Let's talk! Reach out to us. #Pharma

🎙️ Excited to share my recent conversation with Ben from Ben | The SaaS CFO on his podcast! We dive into the future of biotech and our work at Converge Bio . Tune in here: 🍏 Apple Podcasts:podcasts.apple.com/us/podcast/con… 🎧 Spotify: open.spotify.com/episode/75wtyS…

I'll be heading out today to showcase Converge Bio at #biotools. Looking forward to connecting with judges, investors, and fellow entrepreneurs. See you there! #BTIRoadTour2025 #StartupPitch #StartupInnovation #Innovation #LifeSciences

I refuse to mix Shakespeare with amino acids. “Chatty” bio‑LLMs waste model weights on English tokens or bolt giant chat heads onto protein models. Use lean tools like ESM‑2 for folds and ProtGPT‑2 for design, then add a tiny LLM to use the output. Stop paying for bloated prose.